Latest Alendronic acid Stories
Bloomberg reported on April 4th, 2013 that the second Fosamax trial over claims Merck allegedly hid risks that Fosamax could cause femur fractures is set to begin April 9th. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Fosamax side effects. San Diego, CA (PRWEB) April 08, 2013 AttorneyOne.com, a recognized authority on law, updated the...
Greater Reduction in the Risk of Vertebral Fracture is One of the Greatest Unmet Needs in Osteoporosis and Osteopenia, According to a New Report from Decision Resources BURLINGTON, Mass., April 4, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European primary care physicians (PCPs) agree that efficacy on hip fracture risk reduction is one of the attributes that...
The Firm continues to investigate Fosamax lawsuits on behalf of individuals who allegedly suffered Fosamax femur fractures due to long-term use of the drug. New York, New York (PRWEB) April 01, 2013 Fosamax lawsuits involving femur fracture allegations continue to make their way through state and federal courts, Bernstein Liebhard LLP reports. Court records indicate opening statements in the first trial of hundreds of Fosamax femur fracture claims pending in U.S. District Court, District...
The Firm continues to investigate Fosamax lawsuits on behalf of individuals who allegedly suffered Fosamax femur fractures due to long-term use of the drug. New York, New York (PRWEB) March 28, 2013 Fosamax lawsuits continue to move forward in a consolidated litigation now underway in New Jersey Superior Court, Bernstein Liebhard LLP reports. According to the calendar posted on the Court’s website, the Fosamax litigation’s next monthly management conference has been scheduled for...
Bernstein Liebhard LLP investigating lawsuits on behalf of individuals injured as a result of drug side effects. New York, NY (PRWEB) February 16, 2013 The U.S. Food & Drug Administration (FDA) is considering a rule change that could pave the the way for individuals allegedly injured by generic versions of popular medications, including Fosamax, to pursue generic drugs lawsuits against their manufacturers, Bernstein Liebhard LLP reports. The agency recently confirmed to Reuters that...
The Firm is currently investigating Fosamax femur fracture lawsuits on behalf of individuals who suffered atypical femur fractures, allegedly due to Fosamax. New York, New York (PRWEB) February 01, 2013 The federal judge overseeing Fosamax lawsuits in the U.S. District Court for the Southern District of New York has issued a ruling allowing a plaintiff to add an allegation that Fosamax caused her to suffer a femur fracture, Bernstein Liebhard LLP reports. According to court documents,...
Bernstein Liebhard LLP is currently evaluating Fosamax lawsuits on behalf of individuals who suffered atypical femur fractures allegedly due to their use of the drug. New York, New York (PRWEB) January 26, 2013 Fosamax lawsuits continue to move forward in the consolidated litigation underway in New Jersey Superior Court, Atlantic County, Bernstein Liebhard LLP reports. According to court records, the next status conference in the New Jersey litigation has been scheduled for February...
SAN ANTONIO, Texas, Jan. 22, 2013 /PRNewswire/ -- BINOSTO®( )(alendronate sodium) Effervescent Tablet for oral solution 70 mg, was named a "Product to Watch" in the January 7, 2013, edition of BioCentury, the Bernstein Report on BioBusiness newsletter. BioCentury is an internationally recognized leader in providing pharmaceutical analysis and data, along with value-added information for biotechnology and pharmaceutical companies. BINOSTO, a product of Mission Pharmacal and the...
Law firm offers no win - no fee promise for clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side effects, such as femur fractures, osteonecrosis of the jaw injury, esophageal cancer, and severe musculoskeletal pain. (PRWEB) December 28, 2012 Law Firm Offers No Win - No Fee Promise For Clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side...
Bernstein Liebhard LLP continues to investigate Fosamax lawsuits on behalf of individuals who suffered atypical femur fractures allegedly due to their use of Fosamax. New York, NY (PRWEB) December 01, 2012 As Fosamax lawsuits continue to move forward, a new study has found that patients who take bisphosphonates like Fosamax may be at increased risk for upper gastrointestinal cancer, Bernstein Liebhard LLP reports. The study compared 8,636 men and women who had a recorded incident of...
